DV
Dividend Vision

IBRN — iShares Neuroscience and Healthcare ETF

iShares Neuroscience and Healthcare ETF (IBRN)

IBRN carries a 0.47% expense ratio. Total return is 61.6% over the past 4 years, 40.5 points behind SPY at 102.1%. Its deepest 1-year drawdown was 9.1%.

IBRN is an equity ETF that focuses on companies in the neuroscience and healthcare sectors, offering exposure to specialized medical innovation and treatment development. The fund has a very low distribution rate of 0.14% with a competitive expense ratio of 0.47%, reflecting a growth-oriented profile rather than an income-focused strategy. This ETF appeals primarily to investors seeking sector-specific healthcare exposure and potential capital appreciation, rather than those prioritizing dividend income.

IBRN key facts

Issuer
iShares
Asset type
ETF
Asset class
Equity
Inception date
08/24/2022
Expense ratio
0.47%
Trailing yield
0.82%
Last close
$39.14
AUM
$5,682,753
Average volume
1746.0
Ex-dividend date
12/16/2025
Payment date
12/18/2026
Beta
0.87
P/E ratio
28.1421